A pilot study using residual newborn dried blood spots to assess the potential role of cytomegalovirus and Toxoplasma gondii in the etiology of congenital hydrocephalus

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 97, Issue 7, 2013, Pages 431-436

  Simeone, Regina M ^a,b   Rasmussen, Sonja A ^a   Mei, Joanne V ^c   Dollard, Sheila C ^d   Frias, Jaime L ^a,e   Shaw, Gary M ^f   Canfield, Mark A ^g   Meyer, Robert E ^h   Jones, Jeffrey L ⁱ   Lorey, Fred ^j   Honein, Margaret A ^a  

^a NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^b OAK RIDGE INSTITUTE FOR SCIENCE AND EDUCATION   (United States)

^c NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

^d NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^e McKing Consulting Corporation   (United States)

^f STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g TEXAS DEPARTMENT OF STATE HEALTH SERVICES   (United States)

^h State Center for Health Statistics   (United States)

ⁱ CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^j CALIFORNIA DEPARTMENT OF PUBLIC HEALTH   (United States)

more..

Author keywords

Congenital infections; Cytomegalovirus; Hydrocephalus; Newborn dried blood spots; Toxoplasma gondii

Indexed keywords

IMMUNOGLOBULIN M; VIRUS DNA;

ADULT; ARTICLE; BIRTH DEFECT; CONGENITAL HYDROCEPHALUS; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC TEST ACCURACY STUDY; DRIED BLOOD SPOT TESTING; FEMALE; HUMAN; INTRAUTERINE INFECTION; MAJOR CLINICAL STUDY; NEWBORN; PRIORITY JOURNAL; RISK FACTOR; TOXOPLASMA GONDII;

CONGENITAL INFECTIONS; CYTOMEGALOVIRUS; HYDROCEPHALUS; NEWBORN DRIED BLOOD SPOTS; TOXOPLASMA GONDII;

CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DRIED BLOOD SPOT TESTING; FEMALE; HUMANS; HYDROCEPHALUS; INFANT, NEWBORN; MALE; RETROSPECTIVE STUDIES; TOXOPLASMA; TOXOPLASMOSIS, CONGENITAL;

CYTOMEGALOVIRUS; TOXOPLASMA GONDII;

EID: 84880699619     PISSN: 15420752     EISSN: 15420760     Source Type: Journal    
DOI: 10.1002/bdra.23138     Document Type: Article

References (40)

1. Atkinson C, Walter S, Sharland M, et al. 2009. Use of stored dried blood spots for retrospective diagnosis of congenital CMV. J Med Virol 81:1394-1398.
2. Azam AZ, Vial Y, Fawer CL, et al. 2001. Prenatal diagnosis of congenital cytomegalovirus infection. Obstet Gynecol 97:443-448.
3. Bale JF Jr. 2002. Congenital infections. Neurol Clin 20:1039-1060, vii.
4. Bale JF Jr. 2009. Fetal infections and brain development. Clin Perinatol 36:639-653.
5. Barbi M, Binda S, Primache V, et al. 1996. Diagnosis of congenital cytomegalovirus infection by detection of viral DNA in dried blood spots. Clin Diagn Virol 6:27-32.
6. Bate SL, Dollard SC, Cannon MJ. 2010. Cytomegalovirus seroprevalence in the United States: the national health and nutrition examination surveys, 1988-2004. Clin Infect Dis 50:1439-1447.
7. Boppana SB, Fowler KB, Pass RF, et al. 2005. Congenital cytomegalovirus infection: association between virus burden in infancy and hearing loss. J Pediatr 146:817-823.
8. Boppana SB, Ross SA, Novak Z, et al. 2010. Dried blood spot real-time polymerase chain reaction assays to screen newborns for congenital cytomegalovirus infection. JAMA 303:1375-1382.
9. Choi KY, Schimmenti LA, Jurek AM, et al. 2009. Detection of cytomegalovirus DNA in dried blood spots of Minnesota infants who do not pass newborn hearing screening. Pediatr Infect Dis J 28:1095-1098.
10. Dollard SC, Grosse SD, Ross DS. 2007. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol 17:355-363.
11. Gilbert RE, Thalib L, Tan HK, et al. 2007. Screening for congenital toxoplasmosis: accuracy of immunoglobulin M and immunoglobulin A tests after birth. J Med Screen 14:8-13.
12. Henderson LO, Powell MK, Hannon WH, et al. 1997. An evaluation of the use of dried blood spots from newborn screening for monitoring the prevalence of cocaine use among childbearing women. Biochem Mol Med 61:143-151.
13. Honein MA, Devine O, Sharma AJ, et al. 2012. Modeling the potential public health impact of prepregnancy obesity on adverse fetal and infant outcomes. Obesity (Accepted Article. DOI: 10.1002/oby.20156).
14. James HE. 1992. Hydrocephalus in infancy and childhood. Am Fam Physician 45:733-742.
15. Jamieson DJ, Kourtis AP, Bell M, et al. 2006. Lymphocytic choriomeningitis virus: an emerging obstetric pathogen? Am J Obstet Gynecol 194:1532-1536.
16. Jara M, Hsu HW, Eaton RB, et al. 2001. Epidemiology of congenital toxoplasmosis identified by population-based newborn screening in Massachusetts. Pediatr Infect Dis J 20:1132-1135.
17. Jones JL, Kruszon-Moran D, Sanders-Lewis K, et al. 2007. Toxoplasma gondii infection in the United States, 1999-2004, decline from the prior decade. Am J Trop Med Hyg 77:405-410.
18. Kankaanpää P, Suolinna E-M, Østrup J. Automated Toxoplasma gondii IgM Immunoassay for Neonatal Screening of Congenital Toxoplasmosis. Available at: http://shop.perkinelmer.com/content/relatedmaterials/posters/sps_automatedtoxoplasmamimmunoassayii.pdf. Accessed on August 7, 2012.
19. Kenneson A, Cannon MJ. 2007. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol 17:253-276.
20. Kravetz JD, Federman DG. 2005. Toxoplasmosis in pregnancy. Am J Med 118:212-216.
21. Lebech M, Andersen O, Christensen NC, et al. 1999. Feasibility of neonatal screening for toxoplasma infection in the absence of prenatal treatment. Danish Congenital Toxoplasmosis Study Group. Lancet 353:1834-1837.
22. Lipitz S, Achiron R, Zalel Y, et al. 2002. Outcome of pregnancies with vertical transmission of primary cytomegalovirus infection. Obstet Gynecol 100:428-433.
23. McAllister JP. 2012. Pathophysiology of congenital and neonatal hydrocephalus. Semin Fetal Neonatal Med 17:285-294.
24. Mei JV, Li L, Rasmussen SA, et al. 2011. Effect of specimen storage conditions on newborn dried blood spots used to assess Toxoplasma gondii immunoglobulin M (IgM). Clin Chim Acta 412:455-459.
25. Olariu TR, Remington JS, McLeod R, et al. 2011. Severe congenital toxoplasmosis in the United States: clinical and serologic findings in untreated infants. Pediatr Infect Dis J 30:1056-1061.
26. Olney RS, Moore CA, Ojodu JA, et al. 2006. Storage and use of residual dried blood spots from state newborn screening programs. J Pediatr 148:618-622.
27. Ornoy A, Diav-Citrin O. 2006. Fetal effects of primary and secondary cytomegalovirus infection in pregnancy. Reprod Toxicol 21:399-409.
28. Paul M, Petersen E, Pawlowski ZS, et al. 2000. Neonatal screening for congenital toxoplasmosis in the Poznan region of Poland by analysis of Toxoplasma gondii-specific IgM antibodies eluted from filter paper blood spots. Pediatr Infect Dis J 19:30-36.
29. Rasmussen SA, Hayes EB, Jamieson DJ, et al. 2007. Emerging infections and pregnancy: assessing the impact on the embryo or fetus. Am J Med Genet A 143A:2896-2903.
30. Ross SA, Boppana SB. 2005. Congenital cytomegalovirus infection: outcome and diagnosis. Semin Pediatr Infect Dis 16:44-49.
31. Shibata M, Tankano H, Hironaka T, et al. 1994. Detection of human cytomegalovirus DNA in dried newborn blood filter paper. J Virol Methods 46:279-285.
32. Snijdewind IJ, van Kampen JJ, Fraaij PL, et al. 2012. Current and future applications of dried blood spots in viral disease management. Antiviral Res 93:309-321.
33. Soetens O, Vauloup-Fellous C, Foulon I, et al. 2008. Evaluation of different cytomegalovirus (CMV) DNA PCR protocols for analysis of dried blood spots from consecutive cases of neonates with congenital CMV infections. J Clin Microbiol 46:943-946.
34. Therrell BL, Hannon WH, Pass KA, et al. 1996. Guidelines for the retention, storage, and use of residual dried blood spot samples after newborn screening analysis: statement of the Council of Regional Networks for Genetic Services. Biochem Mol Med 57:116-124.
35. Therrell BL Jr., Hannon WH. 2012. Newborn dried blood spot screening: residual specimen storage issues. Pediatrics 129:365-366.
36. Therrell BL Jr., Hannon WH, Bailey DB Jr., et al. 2011. Committee report: Considerations and recommendations for national guidance regarding the retention and use of residual dried blood spot specimens after newborn screening. Genet Med 13:621-624.
37. Van Landingham M, Nguyen TV, Roberts A, et al. 2009. Risk factors of congenital hydrocephalus: a 10 year retrospective study. J Neurol Neurosurg Psychiatry 80:213-217.
38. Villena I, Ancelle T, Delmas C, et al. 2010. Congenital toxoplasmosis in France in 2007: first results from a national surveillance system. Euro Surveill 15.
39. Wright R, Johnson D, Neumann M, et al. 1997. Congenital lymphocytic choriomeningitis virus syndrome: a disease that mimics congenital toxoplasmosis or cytomegalovirus infection. Pediatrics 100:E9.
40. Zhou Y, Mei JV, WH H. Preparation of dried blood spots for a pilot toxoplasmosis proficiency testing program; 2005 October 24-27; Portland, OR.